Literature DB >> 1716573

Activity of spantide I and II at various tachykinin receptors and NK-2 tachykinin receptor subtypes.

C A Maggi1, R Patacchini, D M Feng, K Folkers.   

Abstract

We compared the ability of spantide I and II to antagonize tachykinins in monoreceptor bioassays. Both peptides antagonized the response to substance P methylester in the guinea-pig ileum (NK-1 receptor-mediated) with greater affinity than the responses mediated by NK-2 or NK-3 receptors in other bioassays. Spantide II was about 10 times more potent than spantide I as an NK-1 antagonist and also possessed some selectivity for the NK-2 receptor subtype present in the hamster trachea. Spantide II is a suitable tool to assess the role of NK-1 receptors in the central and peripheral nervous system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716573     DOI: 10.1016/0014-2999(91)90648-a

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of ruthenium red and capsazepine on C-fibres in the rabbit iris.

Authors:  Z Y Wang; R Håkanson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

2.  Spantide III, a superior tachykinin antagonist with high potency and negligible neurotoxicity.

Authors:  K Folkers; R Hakanson; D M Feng; J C Xu; A Janecka; Z Y Wang
Journal:  Amino Acids       Date:  1993-06       Impact factor: 3.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.